Huiyuan Zhu, Yulong Bie, Jiang Wang, Jing Gao,Bingyue Yang, Haitong Wan*
1Department of Basic Medicine, 2Department of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China 3Institute of Cardio-Cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou 310053, China
Experimental Study on the Protection of Agrimony Extracts from Different Extracting Methods against Cerebral Ischemia-Reperfusion Injury△
Huiyuan Zhu1,3, Yulong Bie1, Jiang Wang1, Jing Gao2,Bingyue Yang2, Haitong Wan3*
1Department of Basic Medicine,2Department of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China3Institute of Cardio-Cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou 310053, China
Agrimonia pilosa;middle cerebral artery occlusion (MCAO); energy metabolism;ischemia-reperfusion injury; rat
C EREBRAL ischemia-reperfusion injury, a lifethreatening disease, refers to ischemia-induced cerebral cell damage that is aggravated by restoring the blood supply.1Tissue damage after stroke involves multiple deleterious mechanisms, and existing therapeutic strategies, such as interventional procedures and surgery, have limitations.2-4Novel therapeutic methods for ischemia stroke are needed to be explored.
Traditional Chinese Medicine (TCM) has the advantage of comprehensive treatment effects on multi-sites, multitargets and overall regulation in ischemia-reperfusion injury. Agrimonia eupatoria, a well investigated traditional medicinal plant, has been largely used in the treatment of headache, abdominal pain, sore throat, bloody discharge,parasitic infections and eczema in China and other Asian countries. Studies have found that Agrimonia pilosa has functions of anti-oxidative, anti-inflamatory, improving lipid metabolism and regulating apoptosis.5,6The active components of Agrimonia pilosa are mainly agrimony,agrimonolide, tannin, organic acids, saponin, etc.7,8Because of the complex composition of agrimony grass, which contains phenol, ester, glycosides, flavonoids, organic acids,and other ingredients, different extraction methods usually get different effective ingredients.
Previous studies on agrimony are mainly in the following aspects:1. Acetylcholinesterase inhibitory effects;92. Free radical scavenging and DNA oxidative damage protecting activities;103. Antioxidant activity and aldose reductase inhibitory potential;114. Glucosidase inhibitory activity of the flavonoid compound and the triterpenoid compound.12Although Agrimonia pilosa treatment, as mentioned above,can improve metabolism and prevent apoptosis after middle cerebral artery occlusion (MCAO), to the best of our knowledge, no publication has compared the therapeutic effects of the extracts of Agrimonia pilosa from different extraction methods. Thus, in the present study, we used neurological function tests, 2,3,5-triphenyltetrazolium chloride (TTC) staining, histologic analysis and quantitative real-time PCR to investigate on a rat model of MCAO the therapeutic effects of extracts of Agrimonia pilosa from different extracting methods, aiming at optimizing the effective extracting methods and exploring the mechanism of Agrimonia pilosa in protecting rat from cerebral ischemicreperfusion injury.
This study has been approved by the local Institutional Animal Care and Use Committee. Adult male SD rats(SCXK2014-0001) weighing 240–270 g were housed in a colony room under conditions of 12 h light/dark cycles and having free access to food and water. All rats were randomly divided into seven experimental groups (8 rats for each group): 1. Sham-operated group, 2. Receiving a transient middle cerebral artery occlusion (MCAO) surgery without treatment, 3. MCAO with treatment of petroleum ether extract of Agrimonia pilosa (PEA group), 4. MCAO with treatment of ethyl acetate extract of Agrimonia pilosa(EAEA group), 5. MCAO with treatment of ethanol extract of Agrimonia pilosa (EEA group), 6. MCAO with treatment of water extract of Agrimonia pilosa (WEA group), 7. MCAO with treatment of nimodipine (NP group). Intragastrical administrations were performed at 0 and 6 hours after MCAO at a dosage of 4g/kg for extracts of Agrimonia pilosa and 0.5mg/kg for nimodipine. Behavioral tests were performed after reperfusion for 24 hours. All rats were euthanized 24 hours after MCAO and brains were removed for histological and immunohistochemical examinations.
The Agrimonia pilosa was acquired in Zhejiang Province,China (Batch number: 140922) and was identified according to the Flora of China. 100g dried Agrimonia pilosa was treated with heating reflux thrice, and then the product was mixed with 10 volumes of petroleum ether, ethyl acetate, 95% ethanol or water for 1 hour. The extracts were filtered through filter paper (Whatman, Maidstone,UK) and concentrated by a rotary evaporator (EYELA,Tokyo, Japan) under reduced pressure at 40°C until reaching a concentration of 0.4g/ml. The yield of each part was: ethyl acetate 5.53%, ethanol 7.40%, water 15.77%,ether 4.62%. Each extract was digested with 2.0%Tween-80 to prepare the extracts for a concentration of 0.4 g/ml, and was stored at 4°C till use.
The MCAO model was induced by the intradermal suture technique as previously described.13Briefly, all rats were anesthetized with 1.5% pentobarbital sodium (50mg/kg,intraperitoneal injection). Make a midline skin incision in the neck, and expose the right common carotid artery(CCA), the external carotid artery (ECA), and the internal carotid artery (ICA). A 3-0 monofilament nylon suture was introduced to right common carotid artery and advanced into the internal carotid artery approximately 18-20mm intracranially from the common carotid artery bifurcation.The thread was left in place for 90 minutes to block the blood supply of the right middle cerebral artery. Then the suture was removed for reperfusion. The temporal muscle and skin were sutured with 4-0 nylon threads. Continuously monitored rectal temperature and maintained it within 36.5°C-37.5°C during the surgery.
Animals of each group were subjected to neurological function test 24h after MCAO using the Zea Longa neurological grading system by a dedicated investigator who was blinded to the experimental groups. Briefly,neurologic findings were scored on a five-point scale:140, no neurologic deficit; 1, mild focal neurologic deficit;2, moderate focal neurologic deficits; 3, severe focal deficits; 4, unable to walk spontaneously with defective consciousness.
Rats (5 per group) were euthanized by decapitation. The brains were sliced coronally into 2mm slices starting 1mm from the frontal pole. The tissue sections were immediately incubated in 1.5% 2,3,5-triphenyltetrazolium chloride (TTC,Sigma, St. Louis, USA) at 37°C for vital staining, and fixed in 4% paraformaldehyde at 4°C overnight before analysis.Brain slices were scanned using a flat-bed scanner. After taking pictures, the infarct area and total area of each brain slice were quantitatively analyzed using the Motic Digital Microscopic Graphic Analysis System (Motic Images Advanced 3.2). The volumes of the infarct tissue and the whole brain were then calculated. The percentages of the infarct volume in whole brain were compared among each group.15
The brain was fixed by transcardial perfusion with a buffered 4% paraformaldehyde solution before paraffinembedded. After that, 4 μm coronal serial sections were processed with a sliding microtome (HM-340 E, Microm,Walldorf, Germany) throughout the ischemic penumbra cortex. Regular hematoxylin-eosin staining was conducted,and the histopathological changes were observed under a light microscope.
The rats were sacrificed under deep anesthesia, and brains were immediately removed, dissected and homogenized in 50 mM phosphate buffers (pH 7.0) containing 0.1 mM duodenum edentate (EDTA) to yield 2% (w/v) homogenate.The homogenate was centrifuged at 2,500 rpm for 10 min at 0°C, and the supernatant was used to determine oxidative product contents and the antioxidant enzyme activities using a BCA protein assay kit (Beyotime Institute of Biotechnology, China).
Modified method of Svoboda and Mosinger16was used to measure the activities of Na+/K+-ATPase and Ca2+-ATPase. The activities were determined by reaction in media A (test mixture) and media B (standard mixture).Media A contains 1.0 M NaCl, 0.2 M KCl, 0.1 M MgCl2, 0.2 M Tris–HCl (pH 7.4) and 0.1 ml of brain homogenate supernatant in a total volume of 2.0 ml. Reaction mixture B contains 10 mM ouabain, 1.0 M NaCl, 0.1 M MgCl2, 0.2 M Tris–HCl (pH 7.4) and 0.1 ml of brain homogenate supernatant in a total volume of 2.0 ml. Then 0.2 ml of 25.0 mM ATP was added to both A and B mixture at 37°C for 15min. After that, 1.0 ml of chilled 10% trichloroacetic acid (TCA) was added to the above mixtures to terminate the reaction. The mixtures were centrifuged at 2,500 rpm for 10 min, and 0.2 ml of supernatant was used for the estimation of inorganic phosphorous (Pi).
Rats were sacrificed under deep anesthesia 24h after ischemia and reperfusion. Brains were immediately removed. Small amount of ischemic brain tissue was collected and placed in liquid nitrogen. Then the frozen tissue was ground into powder, and 50-80mg of the powder was used for total RNA extraction using the TRIzol reagent (BioBasic Inc., Canada).
We took 1 μg of total RNA to synthesize the first strand of cDNA using oligoT primer and MLV reverse transcriptase(Takara, Japan). Primers of P53, Heat shock protein 70(HSP70) and GAPDH were designed with Primer Premier 5.0 and synthesized by Shanghai Sangon Biotech (Table 1). A quantitative real-time PCR system (CFX384, Bio-Rad,USA) and SYBR Premix Ex Taq (Takara, Japan) were use for PCR reaction following the protocol: 95°C for 1 min, 40 cycles at 95°C for 15 sec, 63°C for 25 sec and 72°C for 60 sec. A melt curve analysis was performed to ensure specific amplification. For each target gene, the relative level of expression was normalized against the housekeeping gene GAPDH of the same sample.
One way ANOVA was adopted to compare the neurological function score, the infarction volume, the activity of Na+/K+-ATPase, Ca2+-ATPase, P53 and HSP70 mRNA expression among the groups. Data were presented as mean±SD, and difference was considered significant if P<0.05. Statistical analyses were performed using SPSS software (version 15.0, SPSS Inc.)
Rats in MCAO group were found to have significantly largest infarction volume (29.40±6.50%), and those in NP group had the smallest infarct volume (9.20±2.20%). Compared to the MCAO group, significantly less infarction volumes were observed in WEA, EEA, PEA and EAEA rats, which were 13.50±6.60% (F=4.75, P<0.01), 19.90 ± 6.90%(F=5.23, P<0.01),20.40±5.30%, (F=4.68, P<0.01),and 22.50±10.50% (F=6.25, P<0.05), respectively. There was no infarcted tissue in the brains of sham group mice (Fig. 1, Fig. 2).
Table 1. Primer sequences of rat's genes: P53, Hsp70 and GAPDH
Figure 1. Gross specimen observation on cerebral infarction of MCAO mice with and without treatment (TTC staining). A. Shamoperated group; B. MCAO mice without treatment; C. PEA, MCAO mice treated with petroleum ether extract of Agrimonia pilosa; D. EAEA, MCAO mice treated with ethyl acetate extract of Agrimonia pilosa; E. EEA, MCAO mice treated with ethanol extract of Agrimonia pilosa; F. WEA, MCAO mice treated with water extract of Agrimonia pilosa; G. NP, MCAO mice treated with nimodipine.
HE staining showed that, in the sham group, nucleus and cytoplasm dyed clearly and were distributed evenly. In the MCAO group, volume shrink and swelling occurred in cells;the dye of nucleus was light; the distribution of cells was irregular; and the number of neurons decreased. In the treatment groups, the volume of swollen brain cells reduced; the number of neurons increased; and the nuclear staining was darker (Fig. 3).
The neurological function evaluation showed that the MCAO group had significantly higher scores compared to the sham group (P<0.01). Among the treated groups, only the WEA group had significantly lower neurological score than the MCAO group (P<0.05), indicating its protective effect on preventing MCAO mice from neurological deficits (Fig. 4).
Compared to the sham-operated group, substantial reductions in the activity of Na+/K+-ATPase and Ca2+-ATPase were detected in the MCAO group. Among the treated groups, the activities of Na+/K+-ATPase of WEA group (7.56±0.85 U/mg, F=12.65, P=0.010) and NP group(7.59±1.02 U/mg, F=10.36, P=0.001) were significantly higher than MCAO group. The activity of Ca2+-ATPase in WEA group (3.59±0.22 U/mg, F=8.32, P=0.041), NP group (3.23±1.03 U/mg, F=8.82,P=0.031) and EAEA group (3.86±1.06 U/mg, F=13.65, P=0.008) were also higher than that of MCAO group (Table 2).
The MCAO group showed significantly elevated P53 mRNA expression compared to the sham-operated group (P<0.01). All groups treated with Agrimonia pilosa extractions and the NP group had significantly lower P53 mRNA levels than the MCAO group (P<0.05) (Fig. 5); and that of the WEA group(39.49±10.84) was different from that of the MCAO group more significantly than the other treated groups (P<0.01).
Figure 3. Histological observation on brain tissue of the experimental groups (HE staining×100).
Figure 4. Neurological function evaluation of the experimental groups.
The HSP70 mRNA level of the MCAO, PEA, EEA and WEA groups were significantly higher than that of the sham group (P<0.01), and that of EAEA and NP group were also higher than that of the sham group (P<0.05). There was no statistic difference in HSP70 mRNA expression between MCAO group and any treated group (Fig. 6).
Table 2. Na+/K+-ATPase and Ca2+-ATPase activity of the experimental groups (n=8)
Figure 5. Comparison of P53 mRNA expression 24 hours aftertransient MCAO among experimental groups.
Figure 6. Comparison of HSP70 mRNA expression 24 hours after transient MCAO among experimental groups.*P<0.01, compared with the sham operated group;△P<0.05, compared with the sham operated group.
Since ischemic stroke-induced brain injury often causes irreversible brain damage, it is the worldwide leading cause of death, disability, and massive socioeconomic loss.16Traditional Chinese medicines (TCMs) have successfully been used for centuries to treat stroke, and attract increasing attention from the industry and academia.17-20
Stroke generally involves so many different deleterious processes and biochemical pathways that eventually lead to cellular injury and cell death following reperfusion. A large number of evidence from biochemical and pathological studies of animal models (transgenic and toxin) of neurodegeneration suggests that mitochondrial dysfunction is a common pathological mechanism after stroke. Mitochondrial dysfunction from oxidative stress, mitochondrial DNA deletion, pathological mutation, altered mitochondrial morphology, and interaction of pathogenic proteins with mitochondria leads to neuronal dysfunction and demise.21
The activity of Na+/K+-ATPase and Ca2+-ATPase represents the degree of neuronal injury. After cerebral ischemia-reperfusion injury, mitochondrial permeability increase, leading to more flow of Ca2+in cerebral cell and increased conversion of xanthine dehydrogenase and xanthine oxidase, resulting in increase of free radicals, causing structural damage to chondrocytes,22,23then aggravating chondrocyte respiratory dysfunction and energy metabolism failure. Finally, a severe cycle of oxygen free radicals occurs.24,25Thus, the role of Na+/K+-ATPase activity becomes more important in the secondary injury of neurons after ischemia.26,27In addition, with the reduction or dysfunction of Cyt C, the mitochondrial respiratory chain becomes destroyed, and ATP synthesis decreases, eventually leading to cell death.28Therefore, cerebral cell become an important target of neuroprotection after cerebral ischemia-reperfusion injury.29
In this study, the activity of Na+/K+-ATPase and Ca2+-ATPase decreased in the brain of rats 24 hours after ischemia-reperfusion, indicating the changes of oxygen free radicals and energy metabolism. In MCAO group, the activity of Na+/K+-ATPase and Ca2+-ATPase decreased significantly, demonstrating the important role of cellular energy metabolism in cerebral ischemia-reperfusion injury. On the other hand, the study found that among the treatment groups, WEA group maintained the highest activity of Na+/K+-ATPase and Ca2+-ATPase (P<0.05, respectively),which indicates that water extract of Agrimonia pilosa is the most effective in preventing from the decrease of Na+/K+-ATPase and Ca2+-ATPase in the cerebral ischemiareperfusion injury, and therefore helps to improve energy metabolism of chondriosomes in nerve cells after cerebral ischemia-reperfusion injury.
MacManus et al30for the first time found that there was an apoplectic component for selective neuronal death following global ischemia in rat brain in 1993. Recent studies have demonstrated that cerebral ischemia induced neuronal apoptosis by activating various signal proteins and mediating several signal pathways.31,32Neuronal apoptosis after cerebral ischemia-reperfusion injury is regulated by a large number of apoptosis-related genes, which can be activated via related signal transduction pathways and induce apoptosis by a line of cascade reactions.
Study has shown that Agrimonia pilosa has the function of inducing apoptosis.33In the present study, we use apoptosis-related genes P53 and HSP70 as the key indicators to monitor the effects of different extracts of Agrimonia pilosa on regulating their expression in cerebral ischemia-reperfusion injury, and explore the neuroprotective function and mechanisms of Agrimonia pilosa in cerebral ischemic injury.
Previous studies have found a few reactive genes expressed after ischemia, including P53, which is related to DNA injury and repair.34The expression of P53 is upregulated in a variety of cerebral ischemic animal models, and it acts as an anti-apoptosis factor.35In addition, P53 promotes apoptosis through independent transcription pathways and triggers the apoptosis process by activating Bax mitochondrial translocation.36Mihara et al37showed that P53 protein could directly induce permeabilization of the outer mitochondrial membrane by forming complexes with the protective Bcl-xL and Bcl2 proteins, resulting in cytochrome c release.
HSP70 is a kind of highly conserved protein. Under normal circumstances, HSP70 exists in the cytoplasm, and its expression level is low. HSP70 is activated by a signal transduction pathway after cerebral ischemia-reperfusion injury, and is closely related to ischemic brain damage.There are two mechanisms about HSP70 for brain cell protection: (1) HSP70 facilitates the repair of denatured protein, and promotes the fold and stretch of newly formed polypeptide. (2) HSP70 can bind hydrophobic fraction of unfolded polypeptide and help the fold progress.38As soon as cerebral ischemic and hypoxia occur, oxidative phosphorylation is inhibited in chondriosomes, which decreases the production of ATP. HSP70 rapidly moves into the nucleus, surrounds the nucleolus, and the synthesis rate of HSP70 increases significantly.
Our data showed that expression of P53 and HSP70 significantly increased after cerebral injury in the rat model.Moreover, the expression of P53 was down-regulated in the four groups treated with Agrimonia pilosa extracts. However, no difference in HSP70 mRNA expression was detected between MCAO group and the extracts-treated groups. These results suggested that Agrimonia pilosa might protect cerebral cells from ischemia-reperfusion injury through regulation of cell apoptosis. Whether HSP70 was involved in the protective mechanism need to be determined in future, and further experiments with large sample are needed to better understand the role of apoptosis in the protective mechanism of Agrimonia pilosa.
Based on our study, pharmacotherapy at the early stage of ischemia-reperfusion is helpful in reducing acute ischemic injuries. The results were consistent with the treatment outcome in clinic. Besides, the mechanism of WEA in treating cerebral ischemia-reperfusion injury is related to improving the function and energy metabolism of chondriosome, which is beneficial to the recovery of Na+/K+-ATPase and Ca2+-ATPase activity. On the other hand, inhibiting the expression of apoptosis gene may also be promising for the treatment of cerebral ischemia, which may help to decrease infarction volume and benefit neurologic function recovery.
Since agrimony contains complex chemical constituents of agrimonin, flavonoids, tannins, organic acids and saponins. The water extract contains more agrimonin than other extracts, which contain more flavonoids. Therefore,according to the results of this study, we initially suggested that agrimonin might have effects of anti-apoptosis and improved the metabolic activity of cells. Pharmacodynamics study employing high performance of liquid chromatography to analyze extracts and isolate the effective compound of WEA will be conducted in future.
In conclusion, this study demonstrated a functional and metabolic recovery after WEA treatment in the rat model of cerebral ischemia. The neuro-protective effect of WEA on cerebral ischemic-reperfusion injury might be relevant with its antioxidant potential and upregulation of energy metabolism in neural cells after MCAO.
All authors declared no conflict of interests to disclose.
1. Gao HJ, Liu PF, Li PW, Huang ZY, Yu FB, Lei T, et al. Ligustrazine monomer against cerebral ischemia/reperfusion injury. Neural Regen Res 2015; 10: 832-40. doi: 10.4103/1673-5374.156991.
2. Fisher M. New approaches to neuroprotective drug development. Stroke 2011; 42: S24-27. doi: 10.1161/STROKEAHA.110.592394.
3. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet 2011;377: 1693-702. doi: 10.1016/S0140-6736(11)60325-5.
4. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4:399-415. doi: 10.1038/nrn1106.
5. Ivanova D, Vankova D, Nashar M. Agrimonia eupatoria tea consumption in relation to markers of inflammation,oxidative status and lipid metabolism in healthy subjects.Arch Physiol Biochem 2013; 119: 32-7. doi: 10.3109/13813455.2012.729844.
6. Nho KJ, Chun JM, Kim HK. Agrimonia pilosa ethanol extract induces apoptotic cell death in HepG2 cells. J Ethnopharmacol 2011; 138: 358-63. doi: 10.1016/j.jep.2011.09.008.
7. Pan Y, Liu HX, Zhuang YL, Ding L, Chen, LX. Qiu, F.Studies on isolation and identification of flavonoids in herbs of Agrimonia pilosa. Zhongguo Zhong Yao Za Zhi.2008; 33: 2925-8. Chinese.
8. Correia HS, Batista MT, Dinis TC. The activity of an extract and fraction of Agrimonia eupatoria L. against reactive species. Biofactors 2007; 29:91-104. doi: 10.1002/biof.552029209.
9. Seo UM, Nguyen DH, Zhao BT, Min BS, Woo MH. Flavanonol glucosides from the aerial parts of Agrimonia pilosa Ledeb and their acetylcholinesterase inhibitory effects. Carbohydr Res 2017; 445:75-9. doi: 10.1016/j.carres.2017.04.014.
10. Zhu L, Chen J, Tan J, Liu X, Wang B. Flavonoids from Agrimonia pilosa Ledeb: Free Radical Scavenging and DNA Oxidative Damage Protection Activities and Analysis of Bioactivity-Structure Relationship Based on Molecular and Electronic Structures. Molecules 2017; 22: 195. doi:10.3390/molecules22030195.
11. Kim SB, Hwang SH, Suh HW, Lim SS. Phytochemical Analysis of Agrimonia pilosa Ledeb, Its Antioxidant Activity and AldoseReductase Inhibitory Potential. Int J Mol Sci 2017;18: 379. doi: 10.3390/ijms18020379.
12. Liu X, Zhu L, Tan J, Zhou X, Xiao L, Yang X, et al. Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from Agrimonia Pilosa Ledeb. BMC Complement Altern Med 2014;14:12. doi: 10.1186/1472-6882-14-12.
13. Wang J, Chao F, Han F, Zhang G, Xi Q, Li J, et al. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. J Nucl Med 2013; 54: 785-92. doi:10.2967/jnumed.112.111112.
14. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91. doi: 10.1161/01.str. 20.1.84.
15. Wang Z, Song F, Li J, Zhang Y, Ye Y, Yang J, et al. PET Demonstrates Functional Recovery after Treatment by Danhong Injection in a Rat Model of Cerebral Ischemic-Reperfusion Injury. Evid Based Complement Alternat Med 2014; 430757. doi: 10.1155/2014/430757.
16. Sun L, Jin Y, Dong L, Sumi R, Jahan R, Li Z. The neuroprotective effects of Coccomyxa gloeobotrydiformis on the ischemic stroke in a rat model. Int J Biol Sci 2013; 9:811-17. doi: 10.7150/ijbs.6734.
17. Wan L, Cheng Y, Luo Z, Guo H, Zhao W, Gu Q, et al. Neuroprotection, learning and memory improvement of a standardized extract from Renshen Shouwu against neuronal injury and vascular dementia in rats with brain ischemia. J Ethnopharmacol 2015; 165: 118-26. doi: 10.1016/j.jep.2015.02.027.
18. Guo Z, Cao G, Yang H, Zhou H, Li L, Cao Z, et al. A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways. J Neurosci Res 2014; 92: 1295-306. doi: 10.1002/jnr.23400.
19. Chen L, Zhao Y, Zhang T, Dang X, Xie R, Li Z, et al. Protective effect of Sheng-Nao-Kang decoction on focal cerebral ischemia-reperfusion injury in rats. J Ethnopharmacol 2014; 151: 228-36. doi: 10.1016/j.jep.2013.10.015.
20. Liu Y, Ling Y, Hu W, Xie L, Yu L, Qian X, et al. The herb medicine formula "chong lou fu fang" increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro. Evid Based Complement Alternat Med 2011; 2011: 834231.doi: 10.1093/ecam/nep175.
21. Chaturvedi RK, Beal MF. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci 2008; 1147: 395-412.doi: 10.1196/annals.1427.027.
22. Ying W. NAD+ and NADH in brain functions, brain diseases and brain aging. Front Biosci 2007; 12: 1863-88.doi: 10.2741/2194.
23. Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP.Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 2009; 11: 28-42. doi: 10.1007/s12017-009-8058-1.
24. Chan PH. Role of oxidants in ischemic brain damage.Stroke. 1996; 27: 1124-29. doi: 10.1161/01.STR.27.6.1124.
25. Yamada J, Yoshimura S, Yamakawa H, Sawada M, Nakagawa M, Hara S, et al. Cell permeable ROS scavengers,Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci Res 2003;45:1-8. doi: 10.1016/S0168-0102(02)00196-7.
26. Song D, Xu J, Du T, Yan E, Hertz L,Walz W. Inhibition of brain swelling after ischemia-reperfusion by beta-adrenergic antagonists: correlation with increased K+and decreased Ca2+concentrations in extracellular fluid. Biomed Res Int 2014; 2014: 873590. doi: 10.1155/2014/ 873590.
27. de Lores Arnaiz GR, Ordieres MG. Brain Na(+), K(+)-ATPase Activity In Aging and Disease. Int J Biomed Sci 2014; 10: 85-102.
28. Song T, Liu J, Tao X, Deng JG. Protection effect of atorvastatin in cerebral ischemia-reperfusion injury rats by blocking the mitochondrial permeability transition pore. Genet Mol Res 2014; 13: 10632-42. doi: 10.4238/2014.December.18.5.
29. Christophe M, Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Pharm Des 2006; 12: 739-57. doi: 10.2174/138161206775474242 .
30. Macmanus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global-ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neuroscience Letters 1993;164: 89-92. doi: 10.1016/0304-3940(93)90864-h.
31. Wang LY, Liu J, Li Y, Li B, Zhang YY, Jing ZW. Time-dependent variation of pathways and networks in a 24-hour window after cerebral ischemia-reperfusion injury. BMC Syst Biol 2015; 9:11. doi: 10.1186/s12918-015-0152-4.
32. Guo C, Yin Y, Duan J, Zhu Y, Yan J,Wei G. Neuroprotective effect and underlying mechanism of sodium danshensu[3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae = Danshen] against cerebral ischemia and reperfusion injury in rats. Phytomedicine 2015; 22: 283-9. doi: 10.1016/j.phymed.2014.12.001.
33. Nho KJ, Chun JM, Kim HK. Agrimonia pilosa ethanol extract induces apoptotic cell death in HepG2 cells. J Ethnopharmacol 2011; 138: 358-63. doi: 10.1016/j.jep.2011.09.008.
34. Yang X, Zhang L, Jiang SQ, Gong PL, Zeng FD. Effect of dauricine on apoptosis and expression of apoptogenic protein after transient focal cerebral ischemia-reperfusion injury in rats. Zhongguo Zhong Yao Za Zhi 2009; 34:78-83.
35. Tounai H, Hayakawa N, Kato H, Araki T. Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia:effect of pitavastatin. Metab Brain Dis 2007; 22: 89-104.doi: 10.1007/s11011-006-9040-3.
36. Gu ZT, Li L, Wu F, Zhao P, Yang H, Liu YS. Heat stress induced apoptosis is triggered by transcription-independent p53, Ca2+dyshomeostasis and the subsequent Bax mitochondrial translocation. Sci Rep 2015; 5: 11497. doi:10.1038/srep11497.
37. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T,Pancoska P. p53 has a direct apoptogenic role at the mitochondria. Molecular Cell 2003; 11: 577-90. doi: 10.1016/S1097-2765(03)00050-9.
38. Gong JL, Zhu BM, Murshid A, Adachi H, Song B, Lee A. T Cell Activation by Heat Shock Protein 70 Vaccine Requires TLR Signaling and Scavenger Receptor Expressed by Endothelial Cells-1. J Immunol 2009; 183: 3092-8.doi: 10.4049/jimmunol.0901235.
March 16, 2017.
*Corresponding author Tel: 86-571-86613711, E-mail: wanhaitong@zcmu. edu. cn
△Fund supported by National Science Foundation of China (NSFC) 81503491,81374053, 81630105.
ObjectiveTo study the protective effect of agrimony extracts from different extracting methods on cerebral ischemia-reperfusion injury in rats, in order to optimize the extraction scheme of agrimony.
MethodsMale rats were randomly assigned into seven groups: 1. Sham-operated group, 2. Untreated MCAO group (MCAO), 3. Petroleum ether extract ofAgrimonia pilosatreated MCAO group (PEA), 4. Ethyl acetate extract ofAgrimonia pilosatreated MCAO group (EAEA), 5. Ethanol extract ofAgrimonia pilosatreated MCAO group (EEA), 6. Water extract ofAgrimonia pilosatreated MCAO group (WEA), 7. Nimodipine treated MCAO group (NP). Intragastrical drug administration (i.g) was performed at 0 and 6 hours after MCAO.Neurological function tests were performed after reperfusion for 24 hours, then the brain was removed for the evaluations of the cerebral infarction volume (percentage of total brain volume) by immunohistochemistry,histological changes (hematoxylin-eosin staining), Na+/K+-ATPase, Ca2+-ATPase (modified method of Svoboda and Mosinger), mRNA expression of Tumor suppressor gene (P53) and hot shock protein (HSP70)(quantitative real-time PCR).
ResultsThe neurological function of MCAO group had significantly higher scores than the sham group(P<0.01). The WEA group showed a significantly lower neurological score than the MCAO group (P<0.05),indicating the protective effect of WEA on neurological deficits. The mean infarction volumes of WEA(13.5±6.6%,F=4.75,P<0.01), EEA (19.90±6.90%,F=5.23,P<0.01), PEA (20.40±5.30%,F=4.68,P<0.01) and EAEA (22.50±10.50%,F=6.25,P<0.05) group were all significantly smaller than that of MCAO group (29.40±6.50%). HE staining demonstrated that, compared to the treated groups, the infarcted cerebral tissue of MCAO group had more swelling neural cells, lighter stained nucleus, fewer and irregularly distributed neurons. The activity of Na+/K+-ATPase and Ca2+-ATPase reduced in the MCAO group (3.67±0.48 U/mg,1.28±0.26 U/mg, respectively), and were significantly higher in WEA group (7.56±0.85 U/mg, F=12.65,P=0.010; 3.59±0.22 U/mg, F=8.32, P=0.041, respectively). The MCAO group showed significantly elevated P53 and HSP70 mRNA expressions compared to the sham group (P<0.01, P<0.05). P53 mRNA expressions in Agrimony extracts treated groups were significantly lower than that of the MCAO group (all P<0.01), with the WEA group showing the greatest difference from MCAO group. The HSP70 mRNA level of the treated groups were not significantly different from that of the MCAO group.
ConclusionsTreatment using water extracts of agrimony can promote the best functional and metabolic recovery for rat model of cerebral ischemia-reperfusion injury, which maybe relate with the upregulation of energy metabolism in nerve cells after MCAO.
10.24920/J1001-9294.2017.048
Chinese Medical Sciences Journal2017年4期